Expression of LMP2A Gene of Epstein-Barr Virus in Pichia pastoris
Feng Zhou
Abstract
Feng Zhou
Abstract
Objective: To construct a recombinant plasmid pPICZαA-LMP2A for the expression of latent-infection membrane protein 2A(LMP2A) gene in Pichia pastoris. Methods: The plasmid pPCIcc containing the full length of LMP2A cDNA was digested with EcoR I and Not I and cloned into expression vector pPICZαA. The constructed plasmid pPICZαA-LMP2A was linarized with Sac I and transformed to Pichia pastoris GS115. The transformants were selected by planting cells on YPD/Zeocine plates, and then identified by PCR and expressed in BMGY and BMMY media. The expression product was analyzed by SDS-PAGE. Results: Based on the result of the 12% SDS-PAGE and western-blot, a recombinant protein about 53 KDa expressed in the yeast supernatant was identified to be recombinant LMP2A. Conclusion: The LMP2A cDNA successful expression was the foundation of further research in its fuction and constructed the suitable genetic engineering vaccine against EBV associated disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To construct a recombinant plasmid pPICZαA-LMP2A for the expression of latent-infection membrane protein 2A(LMP2A) gene in Pichia pastoris. Methods: The plasmid pPCIcc containing the full length of LMP2A cDNA was digested with EcoR I and Not I and cloned into expression vector pPICZαA. The constructed plasmid pPICZαA-LMP2A was linarized with Sac I and transformed to Pichia pastoris GS115. The transformants were selected by planting cells on YPD/Zeocine plates, and then identified by PCR and expressed in BMGY and BMMY media. The expression product was analyzed by SDS-PAGE. Results: Based on the result of the 12% SDS-PAGE and western-blot, a recombinant protein about 53 KDa expressed in the yeast supernatant was identified to be recombinant LMP2A. Conclusion: The LMP2A cDNA successful expression was the foundation of further research in its fuction and constructed the suitable genetic engineering vaccine against EBV associated disease.
Key concepts: Pichia pastoris, Recombinant DNA, Plasmid, Molecular biology, Complementary DNA, Biology, Expression vector, Gene